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Summary
 Background Gliomas are the most frequently diagnosed primary intracranial tumours in adults. 
This group incorporates astrocytomas, oligodendrogliomas and ependymomas. 
Glioma treatment in adults usually means surgery and radiotherapy, and in the case 
of poorly differentiated tumours, chemotherapy may also be applied. Failures in 
the treatment of malignant gliomas are mostly local recurrences, intracranial dis-
semination and, very seldom, metastases beyond the central nervous system
 Aim The aim of this paper was to present two instances of extraneural dissemination 
in cases of malignant glioma of the brain.
 Materials/Methods Two patients with dissemination of malignant glioma were diagnosed and treat-
ed in our department during the last 20 years.
 Results Treatment effects were poor.
 Conclusions Extraneural brain tumour dissemination is infrequent and their treatment re-
mains an unsolved problem. Treatment is similar to that of primary glioma, es-
pecially in cases with high dynamics.
  Neither chemotherapy nor radiotherapy are able to produce even a short term 
palliative effect.
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BACKGROUND
Gliomas are the most frequently diagnosed prima-
ry intracranial tumours in adults [1]. This group 
incorporates astrocytomas, oligodendrogliomas 
and ependymomas [2–5]. Glioma treatment in 
adults usually means surgery and radiotherapy, 
and in the case of poorly differentiated tumours, 
chemotherapy may also be applied [6]. Failures 
in the treatment of malignant gliomas are most-
ly local recurrences, intracranial dissemination 
and, very seldom, metastases beyond the central 
nervous system [6,7]. To date there are over 100 
cases of extraneural metastases in cases of malig-
nant glioma described in the literature [6,7]. Most 
commonly, extraneural dissemination occurs in 
young patients aged between 30 and 50 years. 
Metastases are most frequently identiﬁ ed in the 
following organs: bone marrow, lungs and pleu-
ra, lymph nodes, liver, retroperitoneal space and 
cardiac muscle [6–9]. Glioblastoma multiforme 
may spread by means of the cerebrospinal ﬂ uid. 
This occurs in 0.4–0.5% of all patients with neur-
oectodermal tumours, most frequently in gliosa-
rcomas [6]. Choucair [9] reports that extraneu-
ral dissemination was diagnosed in 0.1% of 72 
patients with malignant gliomas. Abbott, quot-
ed by Karen Fink [6], maintains that surgical in-
tervention causes inﬁ ltration of glioma cells into 
the venous system owing to reduced intracranial 
pressure. She reported that, on the basis of the lit-
erature, one can say that there are approximately 
79 documented cases of malignant glioma with ex-
traneural metastases. Among those patients were 
68 adults and 11 children. Denier and colleagues 
[10] described two cases of metastatic glioblasto-
ma metastases involving the lungs, kidneys, liver 
and bones. Liwnicz and Rubinstein [11] report-
ed that ependymomas constitute about 6.2% of 
all gliomas, but that cases of extraneural metas-
tasis among these tumours constitutes around 
16.4% of all glioma metastases. They wrote that 
5% of patients with gliomas suffered from oli-
godendrogliomas, and 5.2% had metastases aris-
ing from oligodendrogliomas.
AIM
The aim of this paper was to present two instanc-
es of extraneural dissemination in cases of ma-
lignant glioma of the brain.
MATERIALS AND METHODS
Between the years 1983 and 2002, 1465 adult pa-
tients were treated for intracranial tumours in 
the Radiotherapy Department of the Provincial 
Oncology Hospital in Opole. Among them were 
965 patients with malignant gliomas. Within this 
group we diagnosed two cases of extraneural dis-
semination.
Case study 1
A female patient, AK, aged 28, underwent par-
tial removal of a brain tumour in May 1987. 
The tumour was located in the right tempo-
ral region. Histopathological diagnosis was: ﬁ -
brillary astrocytoma partly gemistocytic, partly 
anaplastic. The patient was irradiated and re-
ceived doses of 40Gy to the whole brain and 
20Gy to the tumour bed, in combination with 
chemotherapy as follows: Lomustine 120mg/m2 
every 6 weeks. The ﬁ rst dose of Lomustine – 
120mg/m2 – was administered on the ﬁ rst day 
of irradiation. In total 5 doses of Lomustine 
were given. 3 months after completion of chem-
otherapy, the patient developed a painful and 
rapidly growing tumour in the right mandible 
area with accompanying lockjaw. The patient 
was operated. Observations at the time of op-
eration were of a tumour reaching from the 
base of the skull to the lower pharynx and ex-
tending into the right parapharyngeal and par-
aspondylous areas. The histopathological diag-
nosis was of a malignant tumour of neurogenic 
origin. A comparison specimens from the in-
tracranial and parapharyngeal areas showed 
that this was the same tumour. Subsequently, 
the patient was irradiated twice a day, receiv-
ing 72Gy from a Co-60-unit and a 10MeV elec-
tron beam. Following irradiation, chemother-
apy commenced. This consisted of Lomustine 
120mg/m2 every 6 weeks and Cis-platinum 
50mg/m2 on days 1–3 every 4 weeks. The pa-
tient underwent 4 chemotherapy cycles. After 
a further 6 months, a hard painful inﬁ ltration, 
6×4cm, appeared in the right preauricular area 
and the patient developed a fever of up to 39°C. 
Also, abdominal pains developed. The pains 
were concentrated in the lumbar region where 
massive oedema developed, involving the lower 
right leg, the groin and the right iliac fossa. A 
pathological examination of material collected 
from the right groin inﬁ ltration showed a ma-
lignant tumour of neurogenic origin, anaplas-
tic glioma. 14Gy irradiation was administered, 
though the treatment was interrupted owing to 
a high fever and a rapid deterioration in the 
patient’s general condition. The patient died 
the following month, 7 months after the diag-
nosis of dissemination.
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Case study 2
A male patient JŚ, aged 46, was admitted to the 
Provincial Oncology Hospital in October 2001 fol-
lowing surgery to a tumour of the brain in the left 
frontal region. An postoperative examination of 
material revealed a malignant tumour of sarcoma-
tous structure, probably gliosarcoma – a mesoder-
mal and ectodermal tumour of complex texture. 
The patient qualiﬁ ed for combined radiotherapy 
and chemotherapy. Chemotherapy: PCV program: 
Lomustine120mg/m2 + Procarbazine 100mg/m2 
for 14 days + Vincristine 1mg per week for 3 suc-
cessive weeks, every 6 weeks. The patient was irradi-
ated using a 9MV photon beam, receiving 60Gy to 
the tumour bed over 6 weeks. In total, the patient 
underwent 5 chemotherapy cycles. One month 
later, the patient complained of coughing, and 
his temperature rose to 38°C. Examination re-
vealed a regrowth of the tumour at the tumour 
bed. 2nd stage chemotherapy commenced as fol-
lows; Vepesid 100mg/day orally for 10 days, every 2 
weeks and Endoxan 100mg/day orally for 10 days, 
every 4 weeks. A chest X-ray revealed widespread 
mottling in both lung ﬁ elds, especially in the up-
per and central lobes. Lesions were round and of 
various size, merging in places. Bronchoscopy re-
vealed no abnormalities, though cytological ex-
amination of the pleural effusion showed nu-
merous malignant cells of neurogenic origin. An 
ultrasound scan of the abdominal cavity showed 
an oval tumour in the area of the hilus measuring 
35×24mm. The patient died in December 2002, 2 
months after the diagnosis of dissemination.
DISCUSSION
According to the literature, the majority of cases 
of malignant glioma with dissemination beyond 
the central nervous system were associated with 
very rapid spread to many organs, and this proc-
ess was very aggressive in nature [8–10]. Often, in 
cases where dissemination was found, the patient 
was febrile suggesting transmission by both blood 
and lymph vessels [9,10]. Both of the patients de-
scribed above had a fever and the course of dis-
semination was very violent. In 1980 Pasquier 
[8] reported ﬁ nding 72 cases of malignant glio-
mas with extraneural metastases. Among these, 
59.7% were metastases to the lungs and pleura, 
51.4% to the lymph nodes, 30.5% to the bones, 
and 22.2% were metastases to the liver. Among 
metastases to the lymph nodes, 62% of cases were 
metastases to the cervical nodes and 32% were 
metastases to the pulmonary hilus nodes. In pa-
tient AK, described above, dissemination was to 
many lymph node groups while in patient JŚ it 
was to the lungs and pleura. Our observations 
are thus concordant with the observations of 
the authors quoted. According to Liwnicz and 
Rubinstein, all patients with dissemination had 
suffered local recurrence [11]. In our material, 
patient AK had no local recurrence, though a 
quickly growing local recurrence was found in 
patient JŚ. Brain glioma with dissemination be-
yond the central nervous system usually reduces 
survival time [7–10]. Numerous authors suggest 
irradiation and chemotherapy [9] for the treat-
ment of extraneural dissemination. This however 
represents only a palliative or symptomatic treat-
ment and, according to Fink and Schold [6], the 
best way to prevent malignant glioma from me-
tastasising beyond the central nervous system is 
to properly and effectively treat the primary tu-
mour. The cases we have presented here were 
treated chemically, and by irradiation, from the 
moment that dissemination was diagnosed. The 
treatment was of a palliative nature and we ob-
served very short lived effects of therapy (amount-
ing to several weeks) only in patient AK.
CONCLUSIONS
Extraneural brain tumour dissemination is infre-
quent and their treatment remains an unsolved 
problem. Treatment is similar to that of primary 
glioma, especially in cases with high dynamics.
Neither chemotherapy nor radiotherapy are able 
to produce even a short term palliative effect.
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